• Blog
  • Tissue Diagnostics Market Tissue Report

    Tissue Diagnostics Market Tissue Report

    Tissue Diagnostics Market Tissue Report
    Report code - SRHL109 Delivery - 2 Weeks
    Get Free Sample |
    Tissue Diagnostics Market Size, Share, Trend, Forecast, & Industry Analysis: 2022-2027 See more...

    Market Insights

    Tissue Diagnostics Market is likely to witness a steady CAGR of 6.9%, during the forecast period owing to the high prevalence of cancer and chronic diseases, infrastructure development for cancer diagnosis, and increasing healthcare expenditure coupled with growing health awareness. In addition, technological advancements in the field of tissue diagnostics and aging population are further expected to bolster the growth of the market during the forecast period.

    Tissue Diagnostics Market Research Report - Features

    Growth

    6.9% for the next five years

    Major Product Type

    Consumables

    Major Technology Type

    Immunohistochemistry

    Major Disease Type

    Breast Cancer

    Region with the highest demand

    North America

    Key Players

    Abbott Laboratories, Abcam plc., Agilent Technologies, Inc., Cancer Genetics Inc., Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Sakura Finetek Japan Co., Ltd., and Thermo Fisher Scientific Inc.

    Segments' Analysis

    Tissue Diagnostics Market Share: By Product Type

    Based on the product type, the market is segmented as consumables and instruments. The consumables segment is expected to register a higher growth during the forecast period. The growth of the segment is attributed to the cost-effectiveness and ease of use of consumables. Furthermore, the growing number of reagent rental agreements is also one of the major factors driving the growth of the consumables market.

    Tissue Diagnostics Market Share: By Technology Type

    Based on the technology type, the market is segmented as immunohistochemistry, in situ hybridization, digital pathology and workflow management, and special staining. The immunohistochemistry segment is expected to lead the market over the forecast period. The increasing number of chronic diseases can be attributed to the segment's growth, where this technology is mostly used in tissue diagnostics.

    Tissue Diagnostics Market Share: By Disease Type

    Based on the disease type, the market is segmented as breast cancer, gastric cancer, lymphoma, prostate cancer, non-small cell lung cancer, and other diseases. Breast cancer is expected to be the dominant disease type during the forecast period due to its increasing number of cases. In addition, advancements in the field of tissue diagnostics and increase in investment for the development of products for breast cancer diagnosis are expected to contribute to the growth of the segment during the forecast period.

    Tissue Diagnostics Market Share: By Region

    In terms of regions, the market is segmented as North America, Europe, Asia-Pacific, and Rest of the world. Among these regions, North America is expected to be dominant throughout the forecast period. The market growth in this region is majorly due to aging population, increasing number of cancer cases, and increasing healthcare expenditure. In addition, infrastructure development for hospitals and clinical laboratories is expected to drive the growth of the regional market during the forecast period. Europe and Asia-Pacific are also expected to offer substantial growth opportunities over the forecast period.

     

    Market Scope & Segmentation

    Tissue diagnostics is the process of documenting a specific tissue obtained. It can also be defined as the diagnosis of a specific tissue, including its measurement and description, as well as the observation of any abnormalities that may be present. This procedure aids in determining the patient's health and disease status. Immunohistochemistry (IHC), Hematoxylin and Eosin (H&E), and in-situ hybridization are the three major types of tissue diagnostics, with immunohistochemistry (IHC) being the most popular.

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

    Tissue Diagnostics Market Research Report - Features

    Market Segmentation

    5

    Regions Covered

    4

    Countries/Sub-Regions Covered

    17

    No. of Figures & Tables

    >150

    Company Profiles

    10

     

    The tissue diagnostics market is segmented into the following categories. 

    Tissue Diagnostics Market Size, Share, & Forecast, by Product Type:

    • Consumables
      • Regional Analysis: North America, Europe, Asia-Pacific, and RoW
      • Type Analysis: Antibodies, Kits, Reagents, and Probes
    • Instruments
      • Regional Analysis: North America, Europe, Asia-Pacific, and RoW
      • Type Analysis: Slide-Staining Systems, Scanners, Tissue-Processing Systems, and Other Instruments

    Tissue Diagnostics Market Size, Share, & Forecast, by Technology Type:

    • Immunohistochemistry (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • In Situ Hybridization (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Digital Pathology and Workflow Management (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Special Staining (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Tissue Diagnostics Market Size, Share, & Forecast, by Disease Type:

    • Breast Cancer (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Gastric Cancer (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Lymphoma (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Prostate Cancer (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Non-Small Cell Lung Cancer (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Other Diseases (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Tissue Diagnostics Market Size, Share, & Forecast, by End-User Type:

    • Hospitals (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Research Laboratories (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Pharmaceutical Companies (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Contract Research Organizations (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Tissue Diagnostics Market Size, Share, & Forecast, by Region:

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Key Players

    Some of the key players in the tissue diagnostics market are-

    • Abbott Laboratories
    • Abcam plc.
    • Agilent Technologies, Inc.
    • Cancer Genetics Inc.
    • Cell Signaling Technology, Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche Ltd
    • Merck KGaA
    • Sakura Finetek Japan Co., Ltd.
    • Thermo Fisher Scientific Inc.

    Research Methodology

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation by any one of the technology types by disease type.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com

    Frequently Asked Questions (FAQs)

    The tissue diagnostics market is expected to witness an impressive growth of 6.9% CAGR in the coming years.

    Abbott Laboratories, Abcam plc., Agilent Technologies, Inc., Cancer Genetics Inc., Cell Signaling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Merck KGaA, Sakura Finetek Japan Co., Ltd., and Thermo Fisher Scientific Inc are among the key players in the tissue diagnostics market.

    The consumables segment is expected to register a higher growth in the tissue diagnostics market in the next five years.

    The immunohistochemistry segment is expected to lead tissue diagnostics market in the foreseeable future.

    Breast cancer is expected to be the dominant disease type in the tissue diagnostics market in the coming five years.

    North America is expected to be the dominant region in the tissue diagnostics market during the forecast period.